GlassScriptPhysician profile
Stephanie A Bailey
NPI 1477819274
$2,394.46
in general payments reported to CMS, 2019-2025
23 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $742 · 2022: $473 · 2023: $701 · 2024: $224 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $729.29 | 2021-2025 | |
| Lilly USA, LLC | $601.78 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $187.56 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $146.67 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $138.17 | 2021-2022 | |
| Abbott Laboratories | $76.58 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Amgen INC. | $68.75 | 2021-2024 | Tavneos, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.71 | 2023-2025 | Cyltezo |
| Boston Scientific Corporation | $61.82 | 2021-2025 | Watchman Flx |
| Pfizer INC. | $59.31 | 2022-2024 | |
| Integra Lifesciences Corporation | $30.27 | 2021-2022 | |
| Glaxosmithkline, LLC. | $29.54 | 2023 | Trelegy Ellipta, Shingrix |
| Biogen, INC. | $28.80 | 2021-2022 | |
| Dexcom, INC. | $24.59 | 2025 | Dexcom G6 Transmitter |
| Vertex Pharmaceuticals Incorporated | $23.44 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.15 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $17.47 | 2025 | |
| Esperion Therapeutics, INC. | $16.01 | 2021 | |
| Coala Life INC | $15.89 | 2023 | Coala Heart Monitor |
| Novartis Pharmaceuticals Corporation | $15.86 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $13.13 | 2023 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $11.49 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.